110 related articles for article (PubMed ID: 349880)
1. [Role of the C3 nephritic factor in the pathogenesis of glomerulonephritis].
Belovezhov N; Neshev Kh
Vutr Boles; 1978; 17(1):9-12. PubMed ID: 349880
[No Abstract] [Full Text] [Related]
2. C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.
Gewurz AT; Imherr SM; Strauss S; Gewurz H; Mold C
Clin Exp Immunol; 1983 Oct; 54(1):253-8. PubMed ID: 6616970
[TBL] [Abstract][Full Text] [Related]
3. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
[TBL] [Abstract][Full Text] [Related]
4. Meningococcal meningitis associated with persistent hypocomplementaemia due to circulating C3 nephritic factor.
Thompson RA; Yap PL; Brettle RB; Dunmow RE; Chapel H
Clin Exp Immunol; 1983 Apr; 52(1):153-6. PubMed ID: 6861372
[TBL] [Abstract][Full Text] [Related]
5. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
Ng YC; Peters DK
Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
[TBL] [Abstract][Full Text] [Related]
6. C3 nephritic factor in an individual with recurrent viral infection and lipodystrophy.
Myers B; Chambers R; Anderson A; Barry R; Wallington T; Whicher J
J Clin Lab Immunol; 1986 Apr; 19(4):201-4. PubMed ID: 3723590
[TBL] [Abstract][Full Text] [Related]
7. [A new C3NeF assay with zymosan-treated guinea-pig serum].
Ohmori F; Ohi H; Seki M; Watanabe S; Hatano M
Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1423-7. PubMed ID: 3820819
[No Abstract] [Full Text] [Related]
8. Persistently circulating C3 nephritic factor (C3 NeF)-stabilized alternative pathway C3 convertase (C3 CoF) in serum of an 11-year-old girl with meningococcal septicemia--simultaneous occurrence with free C3 NeF.
Wahn V; Müller W; Rieger C; Rother U
Pediatr Res; 1987 Aug; 22(2):123-9. PubMed ID: 3658535
[TBL] [Abstract][Full Text] [Related]
9. A new and specific enzyme-linked immunosorbent assay for the detection of C3 nephritic factor.
Seino J; Fukuda K; Kinoshita Y; Sudo K; Horigome I; Sato H; Saito T; Furuyama T; Yoshinaga K
Tohoku J Exp Med; 1985 Sep; 147(1):111-2. PubMed ID: 3934791
[TBL] [Abstract][Full Text] [Related]
10. C3 nephritic factor in a patient with recurrent Neisseria meningitidis infections.
Teisner B; Elling P; Svehag SE; Poulsen L; Lamm LU; Sjöholm A
Acta Pathol Microbiol Immunol Scand C; 1984 Dec; 92(6):341-9. PubMed ID: 6570081
[TBL] [Abstract][Full Text] [Related]
11. Nephritic factor, C3 splitting activity, C3 and factor B breakdown products in glomerular diseases.
De Vecchi A; Montagnino G; Scalia P; Tarantino A
Ric Clin Lab; 1980; 10(1):93-7. PubMed ID: 6781054
[No Abstract] [Full Text] [Related]
12. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
[TBL] [Abstract][Full Text] [Related]
13. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
Ito S; Tamura N; Fujita T
Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642
[TBL] [Abstract][Full Text] [Related]
14. [C3-nephritic factor in a patient after kidney transplantation (author's transl)].
Starsia Z; Procházková J; Stefanović J; Turková M; Zahradník J
Cas Lek Cesk; 1978 Jul; 117(29-30):905-8. PubMed ID: 356995
[No Abstract] [Full Text] [Related]
15. [Progress in the knowledge of complement. II. Nephritic factors].
Leibowitch J; Lesavre P
Nouv Presse Med; 1979 Jul; 8(30):2447-8. PubMed ID: 493036
[No Abstract] [Full Text] [Related]
16. Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.
Craddock CF; Richards NP; Powell RJ; Morgan AG
Q J Med; 1987 Nov; 65(247):895-8. PubMed ID: 3455546
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of action and clinical importance of C3-nephritic-factor (author's transl)].
Lanzer G; Pogglitsch H; Tilz GP
Acta Med Austriaca; 1981; 8(1):7-13. PubMed ID: 6908995
[TBL] [Abstract][Full Text] [Related]
18. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
[TBL] [Abstract][Full Text] [Related]
19. C3 nephritic factor stabilization of the classic C3 convertase: a role for C2 in C3 nephritic factor activity.
McLean RH; Nilson SH
Proc Soc Exp Biol Med; 1979 Jul; 161(3):358-63. PubMed ID: 461464
[No Abstract] [Full Text] [Related]
20. Hypocomplementemic proliferative glomerulonephritis with C3 nephritic-factor-like activity in multiple myeloma.
Bourke E; Campbell WG; Piper M; Check IJ
Nephron; 1989; 52(3):231-7. PubMed ID: 2662048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
